Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-25341
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHöglinger, Marc-
dc.contributor.authorWirth, Brigitte-
dc.contributor.authorCarlander, Maria-
dc.contributor.authorCaviglia, Cornelia-
dc.contributor.authorFrei, Christian-
dc.contributor.authorRhomberg, Birgitta-
dc.contributor.authorRohrbasser, Adrian-
dc.contributor.authorTrottmann, Maria-
dc.contributor.authorEichler, Klaus-
dc.date.accessioned2022-07-27T08:12:39Z-
dc.date.available2022-07-27T08:12:39Z-
dc.date.issued2022-06-18-
dc.identifier.issn1618-7601de_CH
dc.identifier.issn1618-7598de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/25341-
dc.description.abstractObjective: To evaluate the impact of a DMP for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N?=?538) with diabetes patients receiving usual care (control group; N?=?5050) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach, we compared changes in outcomes from baseline (2017) to 1-year (2017/18) and to 2-year follow-up (2017/19). Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.2 percentage-points, p?<?0.01; 2017/19: 8.4 percentage-points, p?<?0.001]. The hospitalization risk was lower in the intervention group in both years, but only statistically significant in the 1-year follow-up [DiD 2017/18: – 5.7 percentage-points, p?<?0.05; 2017/19: – 3.9 percentage points, n.s.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF – 852; 2017/19: CHF – 909], but this effect was not statistically significant. Conclusion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time.de_CH
dc.language.isoende_CH
dc.publisherSpringerde_CH
dc.relation.ispartofThe European Journal of Health Economicsde_CH
dc.rightshttp://creativecommons.org/licenses/by/4.0/de_CH
dc.subjectDiabetesde_CH
dc.subjectDisease managementde_CH
dc.subjectPrimary carede_CH
dc.subjectProgram evaluationde_CH
dc.subjectQuality of carede_CH
dc.subjectStructured treatment programde_CH
dc.subject.ddc362.1041: Gesundheitsökonomiede_CH
dc.subject.ddc616: Innere Medizin und Krankheitende_CH
dc.titleImpact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world datade_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
dc.identifier.doi10.1007/s10198-022-01486-2de_CH
dc.identifier.doi10.21256/zhaw-25341-
dc.identifier.pmid35716315de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
2022_Hoeglinger-etal_Impact-diabetes-disease-management.pdf551.4 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.